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Abstract: Dysregulation of neurotransmitters (NTs) in the human body are related to 
diseases such as Parkinson’s and Alzheimer’s. The mechanisms of several neurological 
disorders, such as epilepsy, have been linked to NTs. Because the number of diagnosed 
cases is increasing, the diagnosis and treatment of such diseases are important. To detect 
biomolecules including NTs, microtechnology, micro and nanoelectronics have become 
popular in the form of the miniaturization of medical and clinical devices. They offer  
high-performance features in terms of sensitivity, as well as low-background noise. In this 
paper, we review various devices and circuit techniques used for monitoring NTs in vitro 
and in vivo and compare various methods described in recent publications. 
Keywords: microtechnology; microsystems; microelectronics; biosensors; chemical 
messengers; neurotransmitters 
 
1. Introduction 
Neurotransmitters (NTs) are the primary chemical messengers that are released from the neuron 
terminals upon depolarization. It has been shown that the mechanisms of several brain-level diseases 
are linked to NTs, such as Parkinson’s disease and epilepsy. Regarding these two disorders alone, 
statistics show that over 300,000 Canadians and 50 million people worldwide have epilepsy [1], while 
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approximately 100,000 Canadians have Parkinson’s disease [2]. The concentration of some NTs  
in the human body is also related to diseases, such as Alzheimer’s, with a drop in acetylcholine 
concentration [3], or Parkinson’s, with a lack of dopamine (DA), as a result of the progressive 
degeneration of DA-generating cells in the substantia nigra, an NT that regulates movement [4]. The 
mechanisms of other diseases, such as epilepsy, are also linked to NTs, notably gamma-aminobutyric 
acid (GABA, the main inhibitory NT of the brain) and glutamate (GLU, the main excitatory NT of the 
brain). Because NTs have the potential to serve as clinically-relevant biomarkers for specific diseases 
and allow for treatment efficacy, their detection and characterisation are important. A sensor capable 
of continuously measuring NTs, such as DA, in the bloodstream or tissue in vivo would give clinicians 
a valuable window into patients’ health and their response to therapeutics. 
NTs are synthesized and stored in presynaptic terminals and have specific receptors on the postsynaptic 
cells. To detect and monitor NTs, various methods have been applied. Capillary electrophoresis (CE), 
microdialysis and liquid chromatography have been applied for the separation and fractionation of 
NTs, whereas laser-induced fluorescence, immunoassay and mass spectrometry (MS) have been used 
for their detection [5–7]. Because there are insufficient data regarding the origin of urinary  
NTs, studies have focused on measuring NTs in vivo. Additionally, it has been shown that 
neurotransmission occurs on the millisecond to minute time scale, which makes its real-time analysis 
easy to achieve [8,9]. Recently, the miniaturization of common chemical, biological and biotechnological 
manipulations and operations onto a chip (typically made by microfabrication) has given rise to a new 
concept called lab-on-a-chip (LOC). These LOCs include microfluidic structures, which have proven 
useful in the miniaturization of biological and analytical systems [10]. Microfluidics can be integrated 
for in vivo analyses that monitor and measure proteins and molecules, such as NTs. The microfluidic 
structure can be integrated using other techniques, such as microdialysis, to minimize analysis times and 
incorporate online sampling [11]. As an example, microdialysis is an effective tissue sampling strategy 
that has been applied to study many areas of the brain. However, it has not yet been assayed in real 
time; therefore, the method does not provide information on changes in neurotransmitter levels on the 
millisecond to second timescale. Several groups have worked to integrate microfluidics into microdialysis 
probes [12–14], enabling faster analysis times and the ability to sample at lower flow rates, resulting in 
higher sample recovery and greater temporal resolution. However, microdialysis has very low 
temporal resolution, and due to its large size, it is not suitable for implantable sensors [15]. Other 
studies in this area still do not fulfill the criteria that are important for implantable devices, for example 
small size and compactness, and they are also too bulky to be implanted [16]. 
Microsystems based platforms are popular in biological and clinical studies. They are miniaturized 
devices offering high-performance features in terms of sensitivity. They have low background noise, 
use cost-effective components and are able to perform measurements in turbid samples [16]. In biological 
processing, miniaturized systems are used in various applications, such as glucose sensors [17]. 
Though, as electrochemical biosensors were introduced in 1974 [18], scientists have been interested in 
developing these biosensors in various areas, because they are small volume, fast and parallelizable. 
Most biomolecules have extra electrical charges or can be modified with redox-active tags. It is possible to 
apply simple electrochemical detection schemes by using pre-defined electrical excitations to monitor 
molecular responses [19]. In particular, the electrochemical sensor is a completely label-free detection 
platform, which is beneficial to portable sensors [20]. 
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Adams’s laboratory was the first group to develop electrochemical methods for the detection of  
NTs [21]. Since then, electrochemical detection has been extensively used for monitoring NTs [22], 
because of its high sensitivity and fast response times [23–25]. Several NTs, such as DA, norepinephrine 
(NE), serotonin (5-HT) and nitric oxide, are electroactive and can be detected via electrochemical 
detection [26]. Using label-free detection, the analyte can be determined directly with very little or no 
sample preparation. In general, most electrochemical sensors for NTs do not integrate specific 
molecular tags, and they offer a compact and potentially label-free detection solution. They are 
sensitive to the offset and background noise and are normally subjected to noise in the reversible 
hybridization processes, resulting in a sensitivity of around 100 nM for molecular detection, which is 
much higher than the concentrations in regular biochemical experiments [27]. In addition, nonspecific 
binding causes interference, making no discrimination between the signals of specific and non-specific 
interactions [28]. 
Different techniques can be applied to increase the sensitivity, which will be discussed further. 
Additionally, electrical noise could be improved by various techniques, such as additional post-processing 
steps, which can be applied to the employed metallic electrodes, or polymers to facilitate probe  
molecule deposition. 
In this paper, we review the microelectronic techniques used for monitoring NT detection in vitro 
and in vivo. Different types of voltammetry, various categories of electrodes and coatings, CMOS 
technology and dielectrophoresis will be discussed. In addition, we will compare and evaluate methods 
described in publications within the past three years, 2010–2013, in terms of the type of method, the 
detected analyte, the limit of detection and whether it is in vitro or in vivo. 
2. Voltammetry, Amperometry and Potentiostat 
Voltammetry is an electrochemical sensing method that has high temporal and spatial resolution 
and excellent sensitivity, which is suited for studying the dynamics of intercellular communication and 
is extensively used for in vivo and in vitro measurements of NTs [29]. This electrochemical method 
directly detects NTs in the brain. In voltammetry, a low voltage (1–2 V) is applied across an electrode 
interface in solution, and the current developed via chemical reactions occurring at the electrode 
surface is monitored. Bi-directional charge transfer occurs between an electrode and an analyte in solid 
or liquid phase, which uses the applied electrode potential and provides energy for electron transfer 
(i.e., a chemical reaction) to occur. The chemical reactions occur at the electrode’s surface or at very 
short distances away within the probed sample volume, and the resulting charge transfer or current, 
which is proportional to the concentration of the electroactive NTs, are measured.  
On the other hand, amperometry and fast-scan cyclic voltammetry (FSCV) are the two most commonly 
used voltammetric methods of NT measurement. Amperometric transduction is a current-measuring 
sensor with two electrodes, which is controlled at a constant potential and is highly sensitive to the 
concentration of an analyte. It is an accurate electrochemical sensing method commonly used for the 
detection of analytes after separations; however, it has low chemical selectivity, so many compounds 
can be detected at potentials that are sufficient for biogenic amine oxidization. In addition,  
constant-potential amperometry requires a standard potentiostat and is a straightforward technique for 
the collection and analysis of current signals generated at a constant applied potential [30]. Amperometry is 
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also the method chosen for the detection of NT levels when the major electrooxidizable species are 
known and electroactive interferents are either selectively excluded from the sensing electrode surface 
or below the detection limit [26]. Alternatively, FSCV measures the analyte every 100 ms. It has been 
shown that FSCV offers increased specificity, because a chemical signature called a cyclic voltammogram 
is recorded to identify the detected species, and therefore, it is recognized as one of the best choices for 
the detection of endogenous NTs in animals [31]. FSCV can be an excellent electrochemical detection 
method for electroactive NTs, such as DA; however, it requires specialized instrumentation. In 
addition, FSCV offers scan rates greater than 100 V/s and can be suitable for monitoring and 
quantifying DA or other redox-active bio-analytes with rapid changes in various concentrations [19]. 
The detection and quantification of NTs via voltammetry are mainly performed using carbon fiber 
microelectrodes (CFMs). These microelectrodes are commercially available with small-diameter carbon 
fibers, and the fabrication methods are accessible. Carbon-based electrodes have been used extensively 
in voltammetric analysis, because they offer low-cost, chemical stability and wide potential and 
electrocatalytic activity ranges for specific redox reactions. They are also more biocompatible than 
metal electrodes, making them more appropriate for application in biologically-relevant redox systems 
and in vivo analysis [32]. However, these electrodes have poor chemical selectivity, and fouling occurs 
during the test [29]. Electrode fouling is caused by the macromolecules in the brain, as well as the slow 
electron-transfer kinetics at the electrode surface, resulting in low-sensitivity electrochemical 
detection. Bio-fouling also occurs because of the blockage of the electrode surface over time by matrix 
components, such as proteins. Thus, bare electrodes cannot provide stable and reproducible data, due to 
the surface fouling created by the adsorption of oxidized products of some compounds on the electrode 
surface [33]. 
In order to enhance electrode sensitivity, electrode surfaces could be modified using polymer coatings, 
especially in neuroscience applications. The modification of electrodes with semipermeable membrane 
(permselective) polymers enhances the sensitivity and selectively of cationic NT detection [30,34]. 
Various approaches have been developed to modify electrodes using polymer film, nanomaterials, 
covalent modification and self-assembled monolayers, as well as the use of carbon paste electrodes and 
the electrochemical pre-treatment of the electrode [35]. Polymer-modified electrodes prepared via 
electropolymerization have also been applied for the detection of analytes. Selectivity, sensitivity, 
homogeneity, strong adherence to the electrode surface and excellent chemical stability are some 
characteristic of the film. As an example, for electrostatic improvement and the sensitive electroanalysis of 
cationic DA in a neutral solution, Su et al. reported on the thiol-ene chemistry-guided preparation of 
novel thiolated polymeric nanocomposite films of abundant anionic carboxylic groups [36]. 
The measurement by the modified electrode is linear with DA concentration, yielding good  
anti-interferent ability and stability. It has also been shown that all proteins do not behave similarly 
during electroanalytical measurements, and thus, careful consideration of the matrix effect is required 
during biological monitoring. For example, 5-HT, as an oxidative by-product, reduces electrode 
sensitivity, due to electrode fouling over time. Fagan-Murphy et al. examined the effect of different 
biological matrices in terms of 5-HT response on two commonly used carbon-based electrodes [37]. 
They suggested that all biological matrices cannot be treated in a similar way, even if the biological 
elements within a given matrix are potentially similar. 
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In another study, it has been shown that the surfactant, sodium dodecyl sulfate (SDS), in a paste  
(SDS-CP) electrode distinguishes between the cationic form of DA and the anionic electroactive 
species that exist in biological fluids at the physiological pH. Pătraşcu et al. reported on a modified carbon 
paste electrode that incorporates the anionic surfactant sodium dodecyl sulfate (SDS) in the paste  
(SDS-CP) [38]. The detection limit was achieved in the submicromolar range, and the technique has the 
ability to remove the interference of ascorbic acid (AA) and to reduce the interference of uric acid 
(UA). Ensafi et al. reported on a polymer film of Tiron that could be used to modify glassy carbon 
electrode (GCE) and showed the electrochemical behavior of AA, DA and UA at the surface of the 
modified electrode [39]. Various electrocatalytic activities of the modified electrode toward these species 
were achieved. The results showed that the later technique was comparable with the reported methods. 
To increase sensor selectivity against interferences, the electrode surfaces can be modified with Nafion 
to exclude anionic interferents, such as perfluorinated ionomer. In addition, overoxidized polypyrrole 
(OPPy) has recently been deposited on electrodes as a permselective cation-exchange film. Polypyrrole 
(PPy) is a conducting polymer that has been used in the design of bioanalytical sensors. Tseng et al. 
described an implantable microprobe with OPPy/Nafion-modified Pt microelectrode array microsensors 
for the combined, near-real-time monitoring of non-electroactive GLU and electroactive DA with high 
sensitivity and selectivity, as well as an adequate detection limit (Figure 1) [30]. 
Figure 1. (a) Scanning electron microscopy (SEM) image of selective GlutOx immobilization 
on the top left microelectrode site previously modified with a thick overoxidized polypyrrole 
(OPPy) film and Nafion; (b) schematic diagram of the final dual glutamate (GLU)/dopamine 
(DA) sensor configuration. Reproduced with permission from [30]. 
 
In another study, Dengler et al. used a molecularly-imprinted polymer (MIP) electropolymer of 
OPPy for the in vivo detection of DA [40]. The MIP is formed in the presence of a molecule that is then 
extracted, leaving behind a complementary cavity with a chemical affinity for the original molecule.  
Different polymers, such as PPy, poly(1,2-phenylenediamine), polyphenol and polythiophenol, are 
electroactive functional monomers that have been used widely for the development of chemosensors 
based on MIP [41]. Figure 2 shows the general procedure for MIP. 
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Figure 2. General procedure for molecular imprinting with an electroactive functional 
monomer and the typical signal transduction methods employed in detection. Reproduced 
with permission from [41]. 
 
The functional monomer of pyrrole plays an important role in the MIP in terms of recognizing the 
desired DA target molecules. Zachek et al. presented the first FSCV microelectrode arrays (MEA) 
implemented in vivo with the ability to sample from various regions in close spatial proximity 
(equidistant within 1 mm), providing information about neurotransmission across multiple brain 
compartments [42]. The mentioned methods could modify electrodes and increase the sensitivity of the 
device to monitor NTs in a more reliable manner. 
2.1. Voltammetry in Wireless and Implantable Devices 
Voltammetry can be integrated into wireless devices, which makes it a good choice for implantable 
devices. Clark et al. described a biocompatible implantable voltammetric microsensor that can be 
applied to the targets of midbrain DA systems, detecting sub-second DA dynamics with sub-second 
temporal resolution over months in vivo in rats and mice [43]. It has been shown that FSCV offers the 
chemical selectivity needed to differentiate DA from other electroactive species in the brain by 
providing an electrochemical signature (cyclic voltammogram) of the analyte. The system has the 
ability to obtain multiple repeated recordings. In another study, Cao et al. developed an integrated 
flexible implantable probe on a polyimide-film substrate for sensing NTs. The flexibility of the probe 
helps to prevent scar formation in tissues during long-term in vivo monitoring. The assembled sensors 
were calibrated and tested at various concentrations of L-GLU with and without the presence of 
interfering molecules. The results demonstrated good sensitivity and selectivity (Figure 3) [44]. 
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Figure 3. (a) SEM photo of the probe tip and (b) a photo of the assembled devices. 
Reproduced with permission from [44]. 
 
The wireless instantaneous NT concentration system (WINCS) also provides real-time co-monitoring of 
NTs. Shon et al. reported on the use of WINCS-based FSCV for the wireless, real-time, spatially and 
chemically resolved monitoring of adenosine (AD) at a carbon fiber microelectrode (CFM). It has been 
shown that the WINCS supports FSCV at a fiber CFM to provide superior temporal and spatial 
resolution, including chemical specificity [45]. The WINCS provided reliable, high-fidelity FSCV 
measurements of extracellular concentrations of AD, both in vitro and in vivo. These results 
demonstrate that WINCS is well-suited to the in vivo monitoring of AD, and the clinical application of 
AD measurements may prove important in achieving a better understanding of neurochemical 
mechanisms. In another study, Kang et al. used ultra-microelectrode arrays (UMEAs) (Figure 4), a 
square array of 50 × 50 microelectrodes, to detect DA [19].  
Figure 4. (a) Low magnification SEM micrograph showing a section of the ND-UMEA 
(ultra-microelectrode array) in a SiO2 matrix; inset: tilt view at 45° of the ND-UMEA 
projecting above the surrounding SiO2 plane; (b) High resolution SEM micrograph of the 
microstructure of the nanodiamond film; the inset shows an individual ND-UME with a 
“donut”-like geometry. Reproduced with permission from [19]. 
 
UMEAs offer several advantages over macroelectrodes, because of having micron-sized electrodes, 
which enhance the rates of mass transport of the analyte to the electrode surfaces. The compatibility of 
microfabricated nanodiamond UMEA with the FSCV technique was evaluated, which was found to 
offer high temporal resolution for NT detection. Because DA is an electrochemically active compound 
and forms DA-ortho-quinone (DOQ), via oxidation, transferring to electrons and protons, the 
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behavioral and environmental events of DA release occur on a short timescale. Dengler et al. found 
that electroactive species, such as DA, can be adsorbed to an electrode and then rapidly released by 
varying the potential of that electrode [40]. The desorbed species, in this case DOQ, causes a change in 
the local concentration that can be measured via an independent microelectrode in close proximity 
using FSCV. This technique could be applied to create an electrochemical sensor for measuring the 
basal tone or tonic concentrations of an electroactive biochemical in a tissue in real time. The 
application of voltammetry in implantable and wireless devices is promising for NT monitoring. 
2.2. Voltammetry for Simultaneous Measurement of NTs 
The simultaneous measurement of NTs is especially important in plasma and urine samples. Normally, 
AA, DA and UA coexist in body fluids. Because the oxidation potentials of AA, DA and UA are very close 
to one another, their selective detection using bare electrodes is a challenging task. Additionally, due to the 
surface fouling of bare electrodes caused by the adsorption of oxidized products of AA on the electrode 
surface, stability and reproducibility cannot be achieved. At bare electrodes, the selective detection of some 
NTs, such as DA, is impossible, because of interference from other compounds, such as AA and UA, 
which have oxidation potentials that are very close to that of DA [46]. To monitor AA, DA and UA 
simultaneously, conventional solid electrodes undergo an overlapping oxidation potential, and electrode 
fouling occurs because of the adsorption of oxidation products. To prevent this, various polymer films, 
nanoparticles (NPs), self-assembled monolayers and metal-oxide-modified electrodes have been used.  
Atta et al. used a composite-modified platinum (Pt) electrode for the simultaneous determination of 
catecholamines, UA and AA. Atta et al. also constructed an electrochemical sensor based on gold NPs 
and graphite for the selective detection of DA [47]. The gold NPs on the electrode surface amplified the 
signal considerably. Furthermore, the sensor showed sensitive and selective determination of DA in the 
presence of AA and UA. In another study, Wan et al. showed that an electrode modified by a  
poly(3-thiophenemalonic acid) film of a negatively-charged compound could work as an electrocatalyst 
for DA and UA oxidation and as a discriminating layer for DA against AA and UA; and that it could be 
used for the simultaneous determination of these compounds. In addition, using this modified electrode, 
the oxidation current of DA and UA increased significantly, as did the reproducibility and stability. The 
proposed methods can be applied to the detection of DA in human urine samples [48]. 
To monitor DA in the presence of AA and UA, Ni et al. developed a method to study the 
electrochemical behaviour of AA, DA and NA using differential pulse stripping voltammetry (DPSV) [49]. 
This method is simple, fast and cost effective for the simultaneous detection of NTs. Differential pulse 
voltammetry (DPV) is also used to make electrochemical measurements and is considered a derivative 
of linear sweep voltammetry or staircase voltammetry, with a series of fixed voltage pulses 
superimposed on the potential linear sweep or stair steps. The current can be measured directly before 
each potential change, and the difference of the current is plotted as a function of the potential. It was 
concluded that the chemometric methods of analysis would have to be applied to resolve the complex 
voltammetric outputs resulting from the mixture of the three analytes. In another study, Singh et al. 
compared three key coating materials to show their selectivity and fouling resistance to electrodes: 
Nafion, base hydrolyzed cellulose acetate (BCA) and fibronectin [29]. They found that BCA is 
relatively fouling resistant. Fibronectin coating creates moderate losses in sensitivity after coating and 
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fouling. Nafion increases sensitivity for DA and norepinephrine, but not 5-HT. In addition, it has 
selectivity for cationic NTs over anionic metabolites. Even though Nafion resists fouling, both the  
dip-coating and electrodeposition of Nafion result in fouling that is similar to levels observed at bare 
electrodes after exposure to brain tissue. For the simultaneous determination of AA, DA and UA,  
Ensafi et al. used Sulfonazo III-modified film on a glassy carbon (GC) electrode. Sulfonazo III, a  
2,7-bis(2-sulfophenylazo) chromotropic acid tetra sodium salt, is a pH indicator [39]. Thus, the 
electrochemical behavior of the modified electrode depends on the PH of the solution. They showed 
that the modified electrode has electrocatalytic activity toward the oxidation of AA, DA and UA.  
Wan et al. also presented the preliminary results of the simultaneous determination of DA and UA  
in the presence of AA by using a poly(3-thiophenemalonic acid)-modified glassy carbon electrode  
(3-TPA/GC) [35]. They showed that a poly(3-thiophenemalonic acid) film of negatively-charged 
compounds that formed on an electrode surface could act both as an electrocatalyst for DA and UA 
oxidation and as a discriminating layer for DA against AA and UA. Table 1 summarizes recent 
voltammetric techniques for the detection of NTs. 
Table 1. Recent voltammetric techniques for detection of neurotransmitters (NTs). DPV, 
differential pulse voltammetry; FSCV, fast-scan cyclic voltammetry; NE, norepinephrine; 
WINCS, wireless instantaneous NT concentration system; GC, glassy carbon; CFM, carbon 
fiber microelectrode; UA, uric acid. 
Sensor Analyte Limit of Detection 
In Vivo/ 
In Vitro 
Reference 
Implantable, micromachined microprobe 
with a microsensor array for combined 
monitoring of the NTs, GLU and DA, by 
constant potential amperometry 
GLU 
DA 
2.1 ± 0.2 µM 
62 ± 8 µM 
In vitro [30] 
Microelectrode, cyclic voltammetry L-GLU NA In vivo [44] 
Microelectrode array,  
DPV, FSCV, amperometry 
NE NA In vitro [50] 
Carbon fiber microelectrodes, 
Voltammetry 
DA, NEP, 5-HT NA In vivo [29] 
Ultra-microelectrode array, FSCV DA NA In vitro [19] 
Thin-film platinum ultramicroelectrode 
arrays, amperometry 
DA NA In vitro [51] 
Platinum microelectrode, DPV DA 4.5 nM In vivo [46] 
Enzyme-based microelectrode  
arrays, amperometry 
GLU 0.2 M In vitro [52] 
Carbon-fiber microelectrodes, FSCV Simultaneous NE-DA NA In vivo [53] 
Carbon nanofiber electrode, WINCS, 
FSCV 
DA, 5-HT, ascorbic acid 
50 nM and 100 nM, 
respectively 
In vitro [54] 
High definition cyclic  
Voltammetry-based on FSCV 
DA NA In vitro [55] 
Molecule-imprinted polyaniline 
membrane modified on carbon fiber, 
Amperometry, voltammetry 
Glycine NA In vitro [56] 
Sensors 2014, 14 17990 
 
 
Table 1. Cont. 
Sensor Analyte Limit of Detection 
In Vivo/ 
In Vitro 
Reference 
Modified GC electrode, CV DA, UA 
2.6 × 10−7 M 
5.2 × 10−7 M 
In vitro [48] 
Microfabricated microelectrodes, FSCV DA NA In vitro [40] 
Modified glassy carbon  
electrode, amperometry 
Simultaneous NE, 5-HT 
NE: 1.65 × 10−11 M 
5-HT: 1.32 × 10−11 M 
In vitro [57] 
Nanocapillary electrophoretic 
electrochemical chip, amperometry 
DA, NE 30–75 zeptomoles In vitro [58] 
RNA aptamer-based electrochemical 
biosensor, amperometry 
DA 1 µM In vitro [23] 
Capillary zone electrophoresis, 
amperometry 
Six NAAs (neuroactive amino 
acids): Ala, GLU, Asp, Ser, 
Tau, Gly, simultaneously 
Ranging from 10−6 to 
10−7 mol·L−1 
 
In vitro [59] 
Amperometry GLU NA In vitro [60] 
Chitosan coated CFM, amperometry 5-HT 1.6 nM In vivo [61] 
Selective enzyme immobilization on 
arrayed microelectrodes, voltammetry 
GLU 2.5 ± 1.2 µM In vitro [62] 
Carbon paste electrode modified with 
cobalt(II) phthalocyanine  
and tyrosinase, CV 
5-HT 0.84 M In Vitro [63] 
Grafting based GLU-AuNPs modified 
electrode, CV, impedance spectroscopy 
NE, UA 
1.47 × 10−10 M;  
1.68 ×10−11 M 
In vitro [64] 
GLU oxidase biosensor based on mixed 
ceria and titania, NPs, CV 
GLU 
0.594 M and 0.493 M in 
oxygenated and 
deoxygenated conditions 
In vitro [65] 
Gold nanocluster 2D  
modified electrode, DPV 
DA 0.35–0.51 nM In vitro [66] 
FSCV NE NA In vivo [67] 
CE, FSCV 
DA, 5-HT, tyramine, 
octopamine 
1, 1, 2.5, 4 nM In vivo [31] 
FSCV DA, 5-HT, NEP NA In vitro [68] 
Sandwich- type electrochemical 
biosensor, phenyl boronic acid 
immobilized onto gold  
electrodes, voltammetry 
DA 0.2 nM In vitro [69] 
Overall, one of the most important aspects of voltammetry is the low noise and high sensitivity  
in biosensor applications, enabling the simultaneous detection of multiple analytes. Although 
voltammetry is one of the sensitive electrochemical analyses, expensive equipment and complicated 
procedures are required. More work needs to be done in this area to design simple and affordable 
devices for in vitro and in vivo applications. In the following section, we will further discuss carbon 
nanotubes, one of the most used modified electrodes in NT measurement.  
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3. Carbon Nanotubes Electrodes 
Carbon nanotubes (CNTs) were first discovered by Sumio Iijima in 1991 [70]. Since then, studies 
have pursued their potential applications in various areas. CNTs have two structural forms,  
single-walled carbon nanotubes (SWNTs) and multi-walled nanotubes (MWNTs), both of which have 
applications in many areas, such as composite materials, nanoelectronics, energy research and 
biomedicine. CNTs have optical and electrical properties suitable for biomolecule detection. SWNTs 
have semiconducting behaviors, as well as resonance Raman scattering, making them suitable for use 
as nano-probes in biosensors. SWNTs can act as transistors; in this case, the molecules that bind to the 
surface of nanotubes act as the gating molecules and change the conductance of semi-conducting 
SWNTs. MWNTs grown on a platinum substrate were used as an amperometric biosensor. 
Recently, several groups have applied CNT-based electrochemical biosensors for the monitoring of 
diverse biological structures, such as DNA, viruses, antigens and disease markers. These molecules 
can promote electron transfer in electrochemical reactions. The carbon nanotube coating on the 
electrodes is biocompatible and can be used in vivo, as well as in vitro [71]. Carbon-based electrodes 
are biocompatible and low-cost and have good electron transfer kinetics. CNTs can also been 
integrated into electrochemical sensors. They offer enhanced electronic properties and rapid electrode 
kinetics. Thus, CNT-based sensors normally have higher sensitivities, faster electron transfer kinetics 
and lower limits of detection than traditional carbon electrodes. CNTs also offer high electrical 
conductivity, mechanical strength and natural stability. CNT-based sensors can be used in common 
electrochemical methods, such as voltammetry, amperometry, electrical impedance spectroscopy and 
potentiometry. They can also be used as the gate in field-effect transistor (FET) sensors, because of 
high sensitivity to local chemical environments (Figure 5) [72]. 
Figure 5. (a) Schematic structure of a probe-type CNT transistor; (b) schematic diagram of 
the experimental setup for sensing of a CNT transistor in aqueous solution. Reproduced 
with permission from [72]. 
 
To expand the array of analytes beyond electroactive molecules, enzymes are often incorporated 
into biosensors to selectively detect an analyte and create an electroactive product after an enzymatic 
reaction. Biomolecules, such as proteins, enzymes and DNA are easily adsorbed on to the surface of 
CNTs and can be attached directly to functional groups on the CNTs [22]. Adding CNTs to electrodes 
for NT detection could facilitate higher sensitivity and develop the electron transfer kinetics. The most 
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direct electrochemical detection using CNT-based electrodes has focused on monoamines, including 
DA, 5-HT, NE and epinephrine (EP). 
Dip coating CNTs is not reproducible, and sometimes, CNTs lay flat on the surface of the electrode, 
resulting in limited access to the electroactive sites. Xiao et al. introduced a new method for coating CNTs 
on the electrodes [73]. They aligned CNT forests using a chemical self-assembly method, resulting in more 
CNT ends exposed to the analyte. The modified electrodes were sensitive and had high temporal 
resolution, which would facilitate the electrochemical detection of NT release in vivo. Gholizadeh et al. 
also reported a sensitive GLU biosensor based on GLU dehydrogenase/vertically-aligned CNTs (GLDH, 
VACNTs). The results showed that the GLDH/VACNT electrode was a suitable basic electrode for the 
detection of GLU, even without an electron mediator. They also reported the fabrication of a 
vertically-aligned carbon nanotube nanoelectrode array (VACNT-NEA) via the photolithography 
method [74]. The fabricated VACNT-NEA and high-density VACNTs were used as electrochemical 
GLU biosensors. GLU dehydrogenase is covalently attached to the CNTs. The results prove the efficacy 
of the fabricated NEA as a low-cost and high-sensitivity enzymatic biosensor that is well-suited for the 
voltammetric detection of a wide range of clinically important biomarkers. 
In another study, Jacobs et al. modified carbon-fiber microelectrodes (CFMEs) with three  
differently functionalized single-wall carbon nanotubes and measured their responses to 5-HT, DA and 
AA using FSCV. Both carboxylic-acid-functionalized and amide-functionalized CNTs increased the 
oxidative current of CFMEs by approximately 2–6-fold for the cationic NTs, 5-HT and DA, but 
octadecylamine-functionalized CNTs resulted in no significant signal change. PPy, as a conducting 
polymer, can also be used in the design of bioanalytical sensors [75]. Cesarino et al. developed a 
biosensor by using a simple electrocodeposition of MWCNT, PPy and Laccase (Lac) on a platinum (Pt) 
electrode surface [24]. The NT biosensor was applied to detect DA in urine samples using DPV. The 
Pt/MWCNT/PPy/Lac biosensor exhibited a detection limit of 0.14 mM, which was an adequate level for 
monitoring DA in urine, and the obtained results were in full agreement with those from the HPLC 
procedure. Cesarino et al. has also developed a new biosensor by a simple electrocodeposition of  
multi-walled carbon nanotubes (MWCNT), PPy and Lac on the platinum (Pt) electrode surface. The NT 
biosensor was applied to the detection of DA in urine samples using DPV [24]. Peairs et al. proposed 
using oPPY-CNT electrodes instead of Nafion-CNT electrodes for repeated in vivo use, because of their 
reproducible fabrication, selectivity over anions and larger currents in vivo [34]. Immobilizing CNTs into 
these polymers should further improve sensitivity by increasing the electroactive surface area. The 
selectivity for DA over AA was better with oPPY-CNT electrodes. The oPPY-CNT electrodes also 
displayed increased electron transfer kinetics for anions, while Nafion-CNT electrodes did not, proving 
that polymer deposition can affect the electrocatalytic properties of the CNTs. Although Nafion-CNT 
electrodes were easier to make, oPPY-CNT electrodes were more beneficial for DA detection, because 
they were reproducibly fabricated, measured higher currents in vivo and preserved selectivity over anions. 
3.1. CNTs in Simultaneous Detection of Neurotransmitters 
The simultaneous determination of NTs could be facilitated by using CNT. Njagi et al. developed 
implantable carbon microelectrodes that were modified with CNTs dispersed in nafion to quantify 
pharmacological alterations in 5-HT release via DPV [76]. Goyal et al. also reported the simultaneous 
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determination of catecholamines EP and NE using square wave voltammetry (SWV) and a multi-walled 
carbon-nanotube-modified edge plane pyrolytic graphite electrode (MWNT/EPPGE) [77]. SWV has 
also been applied in NT measurement; it has a high sensitivity, suppresses background current and is a 
multipurpose technique for electroanalytical purposes. In another study, the same group used an edge 
plane pyrolytic graphite electrode modified with MWNTs/EPPGE for the quantitative detection of EP in 
the body fluids of smokers and non-smokers, using cyclic voltammetry (CV) and SWV. In this case, the 
voltammetric method was used to analyze EP concentration in plasma samples for the first time [78]. 
Generally, in a natural environment, EP often co-exists with high concentrations of other electroactive 
biomolecules, such as UA, DA, NE and AA, which interfere with one another. In addition, the product of 
EP oxidation (EPchrome) can easily be converted into polymers, blocking its further oxidation on the 
electrode surface. The UA and AA interference was overcome by applying a specific potential region, 
using MWNT/EPPGE for the determination of catecholamines and, thus, preventing UA and AA from 
interfering with the determination. Kamyabi et al. similarly reported the electrochemical behavior of AA, 
DA and UA on the surface of the iron (II) complex-MWNT-modified GC electrode [79]. The modified 
electrode showed sensitivity, selectivity and anti-fouling properties. They concluded that simultaneous or 
independent measurements of the three analytes are possible without any interference. 
A self-assembled monolayer (SAM) can also be used for the modification of electrode surfaces, 
providing fast responses, high sensitivity, antifouling effects and chemical specificity. Pătraşcu et al. 
used a novel captopril/thiophenol (Capt/TP) mixed SAM as a substrate for the selective adsorption of  
5-HT in a solution matrix containing AA and the other commonly encountered NTs. As a result, the 
charge-transfer impedances underwent large changes caused by very small changes in the electrode 
surface due to adsorption, and these changes were detectable [38]. Babaei et al. demonstrated that the 
simultaneous determination of adrenalin (AD) and paracetamol (PAR) can be performed on a single-walled 
carbon nanotube/chitosan/ionic-liquid-modified glassy carbon electrode (SWCNT-CHIT-IL/GCE). 
They showed that a biocompatible polymeric matrix, chitosan (CHIT), displays excellent film-forming 
abilities, high-water permeability and susceptibility to chemical modifications, and chitosan chains can 
associate with CNTs to form a biocompatible nanotube aqueous solution [80]. 
3.2. CNTs in Implantable Devices 
The addition of CNTs to polymer coatings facilitates the measurement of small concentrations of 
NTs in vivo. Koehne et al. integrated a carbon nanofiber (CNF) (Figure 6) electrode array with the 
WINCS for the detection of DA using FSCV [81]. 
CNFs have been shown to be useful as neurochemical recording electrodes, because of their  
high sensitivity, fast electron transfer kinetics, widespread potential window, biocompatibility and 
manufacturing versatility. Additionally, FSCV is a particularly powerful technique that can be used to 
monitor very rapid events, such as neurochemical release. Due to their small size, both micro- and 
nano-electrodes exhibit a double-layer capacitance, which aids in the rapid change of electrode 
potentials and eliminates the distortions in the applied voltage waveform that are observed with larger 
electrodes. WINCS [82], which was developed at the Mayo Clinic, has been used in conjunction with a 
CFM to detect DA, GLU, AD and 5-HT in vitro and in vivo. Overall, CNTs could facilitate higher 
sensitivity and develop electron transfer kinetics for NT detection.  
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Figure 6. Images of CFM and CNF electrodes. Photographs of (a) CFM and (c) CNF 
devices after fabrication. Scanning electron microscopy images of (b) CFM encased in a 
borosilicate capillary and a (d) CNF-based 3 × 3 sensor pad array. High-resolution 
scanning electron microscopy images of (e) CNFs on a sensor pad prior to dielectric 
encapsulation and (f) CNFs on a sensor pad after dielectric encapsulation. Scale bars are  
20 mm, 800 mm, 2 mm and 5 mm, respectively. An imposed tilt of 30° was utilized in (e). 
Reproduced with permission from [81]. 
 
Although numerous encouraging results using CNTs in biomedicine have been published in the past 
several years, more work is yet needed before CNTs can enter the clinic. One of the important issues 
for CNT application is the concern of long-term toxicity. It has been shown that well-functionalized 
carbon nanotubes are not toxic in vitro to cells and in vivo to mice; however, further systematic 
investigations are required. Optimization of the surface functionalization to minimize toxic side effects 
is important. In spite of challenges on the way towards the clinic, carbon nanotubes offer great potential 
for biomedicine and can bring opportunities for different applications in biomedicine [83–85]. Table 2 
summarizes recent carbon nanotube technology for detection of NTs. 
Table 2. Recent carbon nanotube technology for detection of NTs. PAR, paracetamol. 
Sensor Analyte Limit of Detection 
In Vivo/ 
In Vitro 
Reference 
CNT, Voltammetry 5-HT, DA Down to sub-µM levels In vitro [86] 
CNT, Voltammetry, 
chronoamperometry 
AD and PAR 
simultaneously 
AD: 0.09 µmol·L−1 
PAR :0.06 µmol·L−1 
In vitro [80] 
CNT, DPV DA in urine 0.14 mM In vitro [24] 
CNT electrode, SWASV EP 1.63 × 10−9 M In vitro [87] 
CNT Nanoelectrode Array GLU 10 nM 10 nM [74] 
CNT, pyrolytic graphite electrode, 
SWV 
EP, NE 
0.15 × 10−9 and 0:90 × 10−10 M 
respectively 
In vitro [78] 
Carbon-fiber microelectrodes coated 
with Nafion and carbon nanotubes 
(CNTs)/FSCV 
AD 
Nafion-CNT electrode: 
7 ± 2 nM; Bare electrode:  
21 ± 3 nM 
In vitro [88] 
Microelectrodes, CNT, FSCV DA 17 ± 3 nM In vitro [73] 
CNT, GC, DPV AA, DA and UA AA: 0.62 mol·L−1 In vitro [79] 
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Table 2. Cont. 
Sensor Analyte Limit of Detection 
In Vivo/ 
In Vitro 
Reference 
CNT, FSCV 
5-HT, DA and 
AA 
CONH2-CNT electrodes: 90 nM for 
5-HT and 130 nM for DA and for 
COOH-CNT Modified electrodes: 
70 nM for 5-HT and 180 nM for DA 
In vitro [75] 
Integrated in vivo microdialysis 
electrochemical device, CNT 
DA 0.5 nM In vivo [89] 
Thiolated polymeric nanocomposite 
CNTs DPV 
DA 0.4 nmol·L−1 In vitro [36] 
CNT, FSCV DA 
Bare electrodes: 3.7 ± 0.5 nM 
oPPY-CNT electrodes: 3.3 ± 0.6 nM 
Nafion-CNT electrodes:  
4 ± 1 nM 
In vivo [34] 
Ultrasensitive nanowire-transistor DA <10−11 M In vitro [90] 
4. CMOS Technology 
Complementary metal-oxide semiconductor (CMOS) technology is a powerful tool for biosensor 
implementation that is capable of having millions of transistors within system-on-chip and lab-on-chip 
potentials. Moreover, CMOS has the ability to scale up with tens of nanometers of critical feature size, 
meeting the requirements for most biosensing schemes [27]. The low-cost mass production of CMOS 
provides the opportunity to design scalable sensors and provide array implementation for the detection 
of parallel analytes [91]. In addition, CMOS integrated circuits can be used for signal processing in 
implantable and portable applications in biological applications [92,93]. Therefore, using CMOS 
technology in biosensor design could potentially improve the existing sensor performance and open the 
door to various novel sensing modalities. Scaling up CMOS is not expensive. However, due to the 
specific materials available in a CMOS process (particularly aluminium and its oxide) as a transducer, 
this raises the question of the analyte/electrode interface and potential neurotoxicity issues, which is the 
main drawback of CMOS biosensor commercialisation at present [94]. There are also some limitations 
in using CMOS technology. The materials used for the fabrication are not biocompatible, so the device 
must be post-processed. Some techniques have been applied, such as the potentiostatic iodization of the 
exposed aluminum (Al) in phosphoric acid [95], Ti/Pt/Au being stacks deposited and structured via  
lift-off techniques and the plasma-enhanced vapor deposition of silicon oxides and nitrides, followed 
by platinum (Pt) sputtering to create electrodes [96,97]. In addition, the entire chip, as well as the 
connections to the external equipment for read out, or driving, or powering of the chip should be 
protected from the chip, as well. Recently, CMOS technology has been applied for NT monitoring.  
It provides parallel detection, as well as low-detection limits. Rothe et al. have presented an integrated 
electrochemical measurement system based on CMOS technology that allows the detection of  
several analytes in parallel (multi-analyte) and that enables simultaneous monitoring at different 
locations (multi-site). In that study, a label-free, hybridization-based DNA sensor was integrated with 
CMOS technology.  
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Furthermore, the detection of the NT, choline, was achieved by assembling the chip with biosensor 
microprobe arrays [16]. Lu et al. have presented miniaturized CMOS capacitive sensors for monitoring 
DA down to the sub-fM range. The 5 × 5 sensor array contains five parts composed of various 
electrode sizes, and each part group’s five sensors. No additional lithographic steps were needed after 
the CMOS foundry process, and CMOS sensor can be used directly [98]. Ayers et al. have developed a 
CMOS potentiostat circuit that can be scaled to a large array [99]; two post-CMOS fabrication 
methods to incorporate the electrochemical electrode material were presented. The feasibility of  
on-chip electrochemical measurements of DA and catecholamine release from adrenal chromaffin cells 
was demonstrated by proof-of-principle. They concluded that the measurement noise was consistent 
with the typical electrode noise in recordings with external amplifiers. To detect DA, Wang et al. also 
presented interdigitated microelectrodes integrated with CMOS sensing circuitry. The device could be 
used as an immunosensor, with its sensitivity being enhanced by gold NPs.  
Microelectrodes covered by a silicon dioxide layer were fabricated using a maskless post-CMOS 
process. When charged biomolecules bind to the functionalized oxide surface after immobilization, a 
capacitive change will be produced for the underlying electrodes [100]. In another work, Kim et al. 
presented an active CMOS-based electrochemical biosensor array with high-throughput capability 
(100 electrodes) for on-chip amperometric measurement of NT release [101]. The biosensor was 
designed and fabricated using a combination of CMOS integrated circuit (IC) and a photolithography 
process to incorporate working platinum electrodes on-chip. They claim that the high throughput of the 
biosensor array would accelerate the data collection needed to determine the statistical significance of 
changes produced under changing conditions, from several weeks to a few hours (Figure 7). 
Nazari et al. [102] have also presented a 16 × 12-channel neurochemical microarray. Each channel 
acquires bidirectional currents down to pico-amperes, which is proportional to the concentration of a 
neurochemical. In this study, the on-chip gold microelectrodes were biocompatible, which yielded high 
sensitivity and selectivity, eliminating costly excessive wiring and minimizing the interference noise. 
A low-cost on-chip microfluidic network integrated with the CMOS potentiostat array allows for per 
channel sample delivery and provides shorter analysis and response times and a better overall process 
control. The microarray enables the simultaneous analysis of up to 192 neurochemicals in parallel. 
CMOS technology can also be used for implantable neural prosthetics. Poustinchi et al. presented  
a low-power, noise-immune CMOS-based neurochemical circuit for implantation purposes. Using 
electrochemical techniques, the device senses picoscale to microscale currents, corresponding to  
micro-molar NT concentrations. The low-noise characteristics of the device make it suitable for the 
noisy environment often encountered in vivo [103]. The biosensor was designed and fabricated using a 
combination of CMOS (IC) technology and a photolithography process to incorporate working 
platinum electrodes on-chip. They claim that the high throughput of the biosensor array will accelerate 
the data collection needed to determine the statistical significance of changes produced under varying 
conditions from several weeks to a few hours. 
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Figure 7. Packaging of the amperometric chip and live-cell experiment procedure.  
(a) A 3 × 3-mm2 CMOS die with post-fabricated Pt electrodes was wire bonded to a chip 
carrier. Silicone was applied at the surface of the chip carrier, insulating the wire bonds and 
contact pads. This only left the center of the CMOS die exposed where the working 
electrode array was located; (b) Photograph of integrated circuit (IC) biosensor package with 
silicone insulation of wire bonds and contact pads. The area of the IC that was exposed 
without silicone coverage is indicated by the white dashed line; (c) Schematically shown 
experiment procedure from the cell culture on the chip to the live cell recording. 
Reproduced with permission from [101]. 
 
In another study, Goyal et al. used an edge plane pyrolytic graphite electrode modified with  
multi-walled carbon nanotubes (MWNTs/EPPGE) for the quantitative detection of EP in the body 
fluids of smokers and non-smokers using CV and SWV [77]. The voltammetric method was used to 
analyze the EP concentration in plasma samples for the first time. Generally, in a natural environment, 
EP often co-exists with high concentrations of other electroactive biomolecules, such as UA, DA, NE 
and AA, which interfere with one another. In addition, the product of EP oxidation (EPchrome) can 
easily be converted into polymers, blocking its further oxidation on the electrode surface. They overcame 
the UA and AA interference by applying a specific potential region and using MWNT/EPPGE for the 
determination of catecholamines, thus preventing UA and AA from interfering with the determination [77]. 
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Ly et al. investigated the real-time assay of the EP using square-wave anodic stripping voltammetry 
(SWASV) with a modified carbon nanotube electrode (CNE). They used chelate DNA immobilized on 
a catalytic CNT surface. The method showed a lower detection limit than other modifications. Thus, it 
can be attuned to low-detection ranges for in vivo analysis and neuro-current detection. A CMOS 
circuit is also implemented to detect the redox current. Collection efficiency is significantly enhanced 
via reduced electrode separation [87]. Overall, CMOS technology allows for low-cost, large-scale 
production of a device to higher densities and larger array sizes for detection of biomolecules, 
including NTs. Table 3 summarizes recent CMOS techniques for the detection of NTs. Presently,  
one of the drawbacks for CMOS biosensor commercialisation is the specific materials available  
in a CMOS process (particularly, aluminium and its oxide), as a transducer raises the problem  
of the analyte/electrode interface and possible neurotoxicity. To use CMOS as a biosensor,  
post-processing is required, due to the materials used for the fabrication, which are not biocompatible. 
Some techniques have been used to overcome these drawbacks, such as potentiostatic iodization of the 
exposed Al in phosphoric acid, Ti/Pt/Au stacks deposited and structured via lift-off techniques and 
plasma-enhanced vapor deposition of silicon oxides and nitrides, followed by sputtering of Pt to make 
electrodes [94,104,105]. In addition, the whole chip, as well as connections to the external equipment 
for read out, or to drive, or power the chip should be protected from the chip, as well [16]. 
Table 3. Recent CMOS technology for the detection of NTs. 
Sensor Analyte Limit of Detection 
In Vivo/ 
In Vitro 
Reference 
Nafion-coated electrodes, CMOS, CV DA 0.1 μM In vitro [106] 
5 × 5 CMOS capacitive sensor array DA 0.1 fM In vitro [98] 
CMOS-based signal processing 
circuits, carbon nanotube-based sensors 
GLU NA In vitro [107] 
CMOS with sub- µM interdigitated 
microelectrodes covered by inter-metal 
dielectric layer 
DA 200 nM In vitro [100] 
576 electrode CMOS sensor chip 
Choline 0.3 M in vitro 
CMOS Potentiostat 
scalable to large array 
Choline 0.3 μM In vitro [16] 
Active CMOS-based  
electro-chemical biosensor array with 
high throughput capability  
(100 electrodes) 
DA 0.35 µM In vitro [101] 
5. Further Direction 
To explore new techniques for neurotransmitters detection, we have previously presented a hybrid 
microelectronics/microfluidic LOC platform; in vitro experiments have been performed using artificial 
cerebrospinal fluid (ACSF) from Tocris Bioscience and microspheres to test the behaviour of the 
designed LOC [108]. The designed device consists of a fully-integrated dielectrophoresis (DEP)-based 
LOC with electrodes embedded into a microchannel for sampling brain liquid and injecting it through 
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the microchannel for analysis [109]. Dielectrophoresis (DEP) is the movement of particles in a  
non-uniform electric field, which is due to the interaction of the particles’ dipoles and the spatial 
gradient of the electric field. DEP has been applied to the manipulation of biological particles, such as 
bacteria, viruses, proteins, nucleic acids and other biomolecules. Its label-free nature, the simplicity of 
the instrumentation and the ability to induce both negative and positive forces, decrease electrode 
spacing and increase effective field strengths have been made DEP one of the most popular methods of 
particle manipulation in microsystems. It is also applicable to non-conducting particles and can be 
generated either by using a direct current (DC) or alternating current (AC) field. In addition, in the 
DEP technique, a lower voltage is needed than in electrophoresis, which is suitable for integrated LOC 
systems. The proposed platform offers a microfluidic system integrated with a microelectronics chip. 
Both parts are packaged by glass and PDMS followed incorporating into a biocompatible device 
(Figure 8). 
Figure 8. Dielectrophoresis (DEP)-based lab-on-chip (LOC) microsystem architecture 
using planar electrodes. Reproduced with permission from [109]. 
 
Our team has also recently designed and fabricated a fully-differential complementary metal-oxide 
semiconductor (CMOS) capacitive sensor and tested the device functionality by using various organic 
solvents with different dielectric constants [110]. Additionally, we have developed time-based CMOS 
potentiostats, as well as a multi-electrode amperometric biosensor to detect NTs. The multi-electrode 
amperometric biosensor can be applied for multi-neurotransmitters detection purposes, which could  
be valuable to understand many of the human neurological disorders related to NT imbalances  
(Figure 9) [111]. 
Figure 9. Simplified brain implant device system for the monitoring of several 
neurotransmitters’ concentration variations in real time. 
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The integrated potentiostats would also be suitable for the detection circuit of the implantable 
devices, because of the fast performance of the electrochemical techniques, high sensitivity and 
temporal resolution, as well as small probe size. 
6. Applicability 
Because the plasma kinetics of most NTs is in nano-molar ranges [112–114], devices with the 
ability to detect NTs in this range would be applicable. CMOS technology could be a good option for 
this purpose. As an example, Wang et al. designed a CMOS capacitive sensor with sub-µM interdigitated 
microelectrodes covered by an inter-metal dielectric layer, having a 200 nM limit of detection for  
DA [100]. In another study, Lu et al. designed a 5 × 5 CMOS capacitive sensor array for the detection 
of DA in fM ranges [98]. It has been shown that, among different architectures for implementing 
capacitive measurement, charge-based capacitance measurement (CBCM) can achieve unprecedented 
levels of precision, which enables the measuring of extremely small capacitance changes. Moreover, 
due to its capability of fabrication in standard CMOS processes, the technique is recognized as a good 
candidate for use in bio-sensing applications. Additionally, carbon nanotubes have been recently 
popular for their high sensitivity; with a nanomolar limit of detection for NTs [34,75,89,90]. Because 
CNT-based sensors have fast electron transfer kinetics, they offer low limits of detection of NTs. 
Carbon nanofiber electrodes and microelectrodes also offer high sensitivity for NT detection, and the 
limit of detection has been shown to be in nano-molar ranges [31,48,54,56,66,74]. Carbon nanofiber 
electrodes and microelectrodes have a small size with the ability to detect rapid changes of potentials, 
offering nanomolar ranges of NT detection. 
7. Conclusions 
Microelectronic biosensors have the potential to facilitate the development of inexpensive devices 
for molecular diagnostics. NTs, like most other biomolecules, have extra electrical charges or can be 
modified with redox-active tags. By applying simple electrochemical detection schemes and using the 
pre-defined electrical excitations, the monitoring of NTs is possible. This makes microelectronics and 
microsystems-based platforms useful for NT detection. Microelectronics offer high-performance features 
in terms of sensitivity, having low background noise, using cost-effective components and being able to 
perform measurements in turbid samples. In particular, the electrochemical sensor is a completely  
label-free detection platform, which is beneficial to portable sensors. Microtechnology can also be used 
as implantable micro-devices with the potential for neuroprosthetic applications, as well as for the 
investigation of brain circuits in vivo. Because of the complications and cost effectiveness of the current 
devices, research in this area is conducted for simple and cost-efficient devices. In general, micro-devices 
for in vivo and in vitro detection of NTs would be promising in the future for the investigation of brain 
circuits, whereas, in parallel, their potential for neuroprosthetics applications would be valuable. 
Acknowledgment 
The authors would like to acknowledge the financial support from the Canada Research Chair on 
Smart Medical Devices. 
Sensors 2014, 14 18001 
 
 
Author Contributions 
Maryam Mirzaei reviewed all refereed research results, and Mohamad Sawan contributed to the 
description and analysis of presented techniques and to the written of the manuscripts. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. First Official Purple Day in Canada Brings Epilepsy Awareness to Parliament Hill. Available 
online: http://www.epilepsymatters.com/english/index.html (accessed on 12 September 2014). 
2. Facts about Parkinson’s. Available online: http://www.parkinson.bc.ca/Parkinsons-Disease-Fact-Sheet 
(accessed on 23 September 2014). 
3. Lopez, O.L. The growing burden of Alzheimer’s disease. Am. J. Manag. Care 2011, 17,  
S339–S345. 
4. Michel, P.P.; Toulorge, D.; Guerreiro, S.; Hirsch, E.C. Specific needs of dopamine neurons for 
stimulation in order to survive: Implication for Parkinson disease. FASEB J. Off. Publ. Fed. Am. 
Soc. Exp. Biol. 2013, 27, 3414–3423. 
5. Li, T.; Wang, Z.; Xie, H.; Fu, Z. Highly sensitive trivalent copper chelate-luminol 
chemiluminescence system for capillary electrophoresis detection of epinephrine in the urine of 
smoker. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 911, 1–5. 
6. Wang, M.; Slaney, T.; Mabrouk, O.; Kennedy, R.T. Collection of nanoliter microdialysate 
fractions in plugs for off-line in vivo chemical monitoring with up to 2 s temporal resolution.  
J. Neurosci. Methods 2010, 190, 39–48. 
7. Schmerberg, C.M.; Li, L. Mass spectrometric detection of neuropeptides using affinity-enhanced 
microdialysis with antibody-coated magnetic nanoparticles. Anal. Chem. 2013, 85, 915–922. 
8. Croushore, C.A.; Sweedler, J.V. Microfluidic systems for studying neurotransmitters and 
neurotransmission. Lab Chip 2013, 13, 1666–1676. 
9. Marc, D.T.; Ailts, J.W.; Campeau, D.C.A.; Bull, M.J.; Olson, K.L. Neurotransmitters excreted in 
the urine as biomarkers of nervous system activity: Validity and clinical applicability. Neurosci. 
Biobehav. Rev. 2011, 35, 635–644. 
10. Ingber, D.E.; Whitesides, G.M. Lab on a chip: United States of America. Lab Chip 2012, 12,  
2089–2090. 
11. Nandi, P.; Lunte, S.M. Recent trends in microdialysis sampling integrated with conventional and 
microanalytical systems for monitoring biological events: A review. Anal. Chim. Acta 2009, 651, 
1–14. 
12. Nandi, P.; Desai, D.P.; Lunte, S.M. Development of a PDMS-based microchip electrophoresis 
device for continuous online in vivo monitoring of microdialysis samples. Electrophoresis 2010, 
31, 1414–1422. 
Sensors 2014, 14 18002 
 
 
13. Sandlin, Z.D.; Shou, M.; Shackman, J.G.; Kennedy, R.T. Microfluidic electrophoresis chip 
coupled to microdialysis for in vivo monitoring of amino acid neurotransmitters. Anal. Chem. 
2005, 77, 7702–7708. 
14. Zahn, J.D.; Trebotich, D.; Liepmann, D. Microdialysis microneedles for continuous medical 
monitoring. Biomed. Microdevices 2005, 7, 59–69. 
15. Vasylieva, N.; Maucler, C.; Meiller, A.; Viscogliosi, H.; Lieutaud, T.; Barbier, D.; Marinesco, S. 
Immobilization method to preserve enzyme specificity in biosensors: Consequences for brain 
glutamate detection. Anal. Chem. 2013, 85, 2507–2515. 
16. Rothe, J.; Lewandowska, M.K.; Heer, F.; Frey, O.; Hierlemann, A. Multi-Target electrochemical 
biosensing enabled by integrated CMOS electronics. J. Micromech. Microeng. 2011, 21, 
doi:10.1088/0960-1317/21/5/054010. 
17. Piechotta, G.; Albers, J.; Hintsche, R. Novel micromachined silicon sensor for continuous 
glucose monitoring. Biosens. Bioelectron. 2005, 21, 802–808. 
18. Kissinger, P.T.; Felice, L.J.; Riggin, R.M.; Pachla, L.A.; Wenke, D.C. Electrochemical detection 
of selected organic components in the eluate from high-performance liquid-chromatography.  
Clin. Chem. 1974, 20, 992–997. 
19. Kang, W.P.; Raina, S.; Davidson, J.L.; Huang, J.H. High temporal resolution electrochemical 
biosensor using nitrogen-incorporated nanodiamond ultra-microelectrode array. In Proceedings 
of 2012 IEEE Sensors, Taipei, Taiwan, 28–31 October 2012; pp. 1489–1492. 
20. Karadeniz, H.; Kuralay, F.; Abaci, S.; Erdem, A. The recent electrochemical biosensor 
technologies for monitoring of nucleic acid hybridization. Curr. Anal. Chem. 2011, 7, 63–70. 
21. Adams, R.N. Probing brain chemistry with electroanalytical techniques. Anal. Chem. 1976, 48, 
1126A–1138A. 
22. Jacobs, C.B.; Peairs, M.J.; Venton, B.J. Review: Carbon nanotube based electrochemical sensors 
for biomolecules. Anal. Chim. Acta 2010, 662, 105–127. 
23. Farjami, E.; Campos, R.; Nielsen, J.S.; Gothelf, K.V.; Kjems, J.; Ferapontova, E.E. RNA  
aptamer-based electrochemical biosensor for selective and label-free analysis of dopamine. Anal. 
Chem. 2013, 85, 121–128. 
24. Cesarino, I.; Galesco, H.V.; Moraes, F.C.; Lanza, M.R.V.; Machado, S.A.S. Biosensor based on 
electrocodeposition of carbon nanotubes/polypyrrole/laccase for neurotransmitter detection. 
Electroanal 2013, 25, 394–400. 
25. Liu, A.H.; Honma, I.; Zhou, H.S. Electrochemical biosensor based on protein-polysaccharide 
hybrid for selective detection of nanomolar dopamine metabolite of 3,4-dihydroxyphenylacetic 
acid (DOPAC). Electrochem. Commun. 2005, 7, 233–236. 
26. Holland, L.; Leigh, A. Amperometric and voltammetric detection for capillary electrophoresis. 
Electrophoresis 2002, 23, 3649–3658. 
27. Wang, H. Integrated biosensors in CMOS. In Proceedings of the 2011 IEEE 54th International 
Midwest Symposium on Circuits and Systems (MWSCAS), Seoul, Korea, 7–10 August 2011;  
pp. 1–4. 
28. Berggren, C.; Bjarnason, B.; Johansson, G. Capacitive biosensors. Electroanalysis 2001, 13,  
173–180. 
Sensors 2014, 14 18003 
 
 
29. Singh, Y.S.; Sawarynski, L.E.; Dabiri, P.D.; Choi, W.R.; Andrews, A.M. Head-to-Head 
comparisons of carbon fiber microelectrode coatings for sensitive and selective neurotransmitter 
detection by voltammetry. Anal. Chem. 2011, 83, 6658–6666. 
30. Tseng, T.T.C.; Monbouquette, H.G. Implantable microprobe with arrayed microsensors  
for combined amperometric monitoring of the neurotransmitters, glutamate and dopamine.  
J. Electroanal. Chem. 2012, 682, 141–146. 
31. Fang, H.F.; Vickrey, T.L.; Venton, B.J. Analysis of biogenic amines in a single drosophila larva 
brain by capillary electrophoresis with fast-scan cyclic voltammetry detection. Anal. Chem. 2011, 
83, 2258–2264. 
32. Güell, A.G.; Meadows, K.E.; Unwin, P.R.; Macpherson, J.V. Trace voltammetric detection of 
serotonin at carbon electrodes: Comparison of glassy carbon, boron doped diamond and carbon 
nanotube network electrodes. Phys. Chem. Chem. Phys. 2010, 12, 10108–10114. 
33. Atta, N.F.; Galal, a.; Azab, S.M. Electrochemical Determination of neurotransmitters using  
gold nanoparticles on nafion/carbon paste modified electrode. J. Electrochem. Soc. 2012, 159,  
H765–H771. 
34. Peairs, M.J.; Ross, A.E.; Venton, B.J. Comparison of Nafion- and overoxidized polypyrrole-carbon 
nanotube electrodes for neurotransmitter detection. Anal. Methods 2011, 3, 2379–2386. 
35. Tess, M.E.; Cox, J.A. Chemical and biochemical sensors based on advances in materials 
chemistry. J. Pharm. Biomed. Anal. 1999, 19, 55–68. 
36. Su, Z.H.; Liu, Y.; Xie, Q.J.; Chen, L.; Zhang, Y.; Meng, Y.; Li, Y.; Fu, Y.C.; Ma, M.; Yao, S.Z. 
Preparation of thiolated polymeric nanocomposite for sensitive electroanalysis of dopamine. 
Biosens. Bioelectron. 2012, 36, 154–160. 
37. Fagan-Murphy, A.; Watt, F.; Morgan, K.a.; Patel, B.A. Influence of different biological 
environments on the stability of serotonin detection on carbon-based electrodes. J. Electroanal. 
Chem. 2012, 684, 1–5. 
38. Pătraşcu, D.G.; David, V.; Bălan, I.; Ciobanu, A.; David, I.G.; Lazăr, P.; Ciurea, I.; Stamatin, I.; 
Ciucu, a.a. Selective DPV method of dopamine determination in biological samples containing 
ascorbic acid. Anal. Lett. 2010, 43, 1100–1110. 
39. Ensafi, A.A.; Taei, M.; Khayamian, T.; Arabzadeh, A. Highly selective determination of ascorbic 
acid, dopamine, and uric acid by differential pulse voltammetry using poly(sulfonazo III) 
modified glassy carbon electrode. Sens. Actuators B Chem. 2010, 147, 213–221. 
40. Dengler, A.K.; McCarty, G.S. Microfabricated microelectrode sensor for measuring background 
and slowly changing dopamine concentrations. J. Electroanal. Chem. 2013, 693, 28–33. 
41. Sharma, P.S.; Pietrzyk-Le, A.; D’Souza, F.; Kutner, W. Electrochemically synthesized polymers 
in molecular imprinting for chemical sensing. Anal. Bioanal. Chem. 2012, 402, 3177–3204. 
42. Zachek, M.K.; Park, J.; Takmakov, P.; Wightman, R.M.; McCarty, G.S. Microfabricated  
FSCV-compatible microelectrode array for real-time monitoring of heterogeneous dopamine 
release. Analyst 2010, 135, 1556–1563. 
43. Clark, J.; Sandberg, S.; Wanat, M.; Gan, J. Chronic microsensors for longitudinal, subsecond 
dopamine detection in behaving animals. Nat. Methods 2009, 7, 126–129. 
44. Cao, H.; Li, A.L.; Nguyen, C.M.; Peng, Y.B.; Chiao, J.C. An integrated flexible implantable  
micro-probe for sensing neurotransmitters. IEEE Sens. J. 2012, 12, 1618–1624. 
Sensors 2014, 14 18004 
 
 
45. Shon, Y.; Chang, S.; Tye, S. Comonitoring of adenosine and dopamine using the Wireless 
Instantaneous Neurotransmitter Concentration System: Proof of principle. J. Neurosurg. 2010, 
112, 539–548. 
46. Tsai, T.C.; Han, H.Z.; Cheng, C.C.; Chen, L.C.; Chang, H.C.; Chen, J.J.J. Modification of 
platinum microelectrode with molecularly imprinted over-oxidized polypyrrole for dopamine 
measurement in rat striatum. Sens. Actuators B Chem. 2012, 171, 93–101. 
47. Atta, N.F.; Galal, A.; Abu-Attia, F.M.; Azab, S.M. Carbon paste gold nanoparticles sensor for  
the selective determination of dopamine in buffered solutions. J. Electrochem. Soc. 2010, 157,  
F116–F123. 
48. Wan, J.; Xu, G.R.; Liu, Z.S. Poly(3-thiophenemalonic acid) modified glassy carbon electrode for 
selective determination of dopamine and urine acid in the presence of ascorbic acid. Int. J. 
Electrochem. Sci. 2012, 7, 12955–12962. 
49. Ni, Y.; Gui, Y.; Kokot, S. Application of multiway-variate calibration to simultaneous 
voltammetric determination of three catecholamines. Anal. Methods 2011, 3, 385–392. 
50. Pettine, W.; Jibson, M.; Chen, T.; Tobet, S.; Nikkel, P.; Henry, C.S. Characterization of novel 
microelectrode geometries for detection of neurotransmitters. IEEE Sens. J. 2012, 12, 1187–1192. 
51. Wang, J.; Trouillon, R.; Lin, Y.Q.; Svensson, M.I.; Ewing, A.G. Individually addressable  
thin-film ultramicroelectrode array for spatial measurements of single vesicle release. Anal. Chem. 
2013, 85, 5600–5608. 
52. Quintero, J.E.; Dooley, D.J.; Pomerleau, F.; Huettl, P.; Gerhardt, G.A. Amperometric 
measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical 
slices: Role of voltage-sensitive Ca2+ alpha(2)delta-1 subunit. J. Pharmacol. Exp. Ther. 2011, 
338, 240–245. 
53. Park, J.; Takmakov, P.; Wightman, R.M. In vivo comparison of norepinephrine and dopamine 
release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry. J. Neurochem. 
2011, 119, 932–944. 
54. Zhang, D.A.; Rand, E.; Marsh, M.; Andrews, R.J.; Lee, K.H.; Meyyappan, M.; Koehne, J.E. 
Carbon nanofiber electrode for neurochemical monitoring. Mol. Neurobiol. 2013, 48, 380–385. 
55. Bucher, E.S.; Brooks, K.; Verber, M.D.; Keithley, R.B.; Owesson-White, C.; Carroll, S.; 
Takmakov, P.; McKinney, C.J.; Wightman, R.M. Flexible software platform for fast-scan cyclic 
voltammetry data acquisition and analysis. Anal. Chem. 2013, 85, 10344–10353. 
56. Zeng, H.J.; Wang, D.S.; Yu, J.S. A molecule-imprinted polyaniline membrane modified on 
carbon fiber for detection of glycine. BioMed. Mater. Eng. 2014, 24, 1085–1091. 
57. Revin, S.B.; John, S.A. Electrochemical sensor for neurotransmitters at physiological pH using a 
heterocyclic conducting polymer modified electrode. Analyst 2012, 137, 209–215. 
58. Wu, R.G.; Yang, C.S.; Cheing, C.C.; Tseng, F.G. Nanocapillary electrophoretic electrochemical 
chip: Towards analysis of biochemicals released by single cells. Interface Focus 2011, 1,  
744–753. 
59. Ge, S.L.; Wang, H.; Wang, Z.F.; Cheng, S.; Wang, Q.J.; He, P.G.; Fang, Y.Z. Simultaneous 
determination of neuroactive amino acids in serum by CZE coupled with amperometric 
detection. Chromatographia 2013, 76, 149–155. 
Sensors 2014, 14 18005 
 
 
60. Grabner, C.P.; Zenisek, D. Amperometric resolution of a prespike stammer and evoked phases of 
fast release from retinal bipolar cells. J. Neurosci. 2013, 33, 8144–8158. 
61. Ozel, R.E.; Wallace, K.N.; Andreescu, S. Chitosan coated carbon fiber microelectrode for selective 
in vivo detection of neurotransmitters in live zebrafish embryos. Anal. Chim. Acta 2011, 695,  
89–95. 
62. Tseng, T.T.C.; Yao, J.; Chan, W.C. Selective enzyme immobilization on arrayed microelectrodes 
for the application of sensing neurotransmitters. Biochem. Eng. J. 2013, 78, 146–153. 
63. Apetrei, I.M.; Apetrei, C. Amperometric tyrosinase based biosensors for serotonin detection. 
Rom. Biotechnol. Lett. 2013, 18, 8253–8262. 
64. Kesavan, S.; Revin, S.B.; John, S.A. Fabrication, characterization and application of a grafting 
based gold nanoparticles electrode for the selective determination of an important neurotransmitter.  
J. Mater Chem. 2012, 22, 17560–17567. 
65. Ozel, R.E.; Ispas, C.; Ganesana, M.; Leiter, J.C.; Andreescu, S. Glutamate oxidase biosensor 
based on mixed ceria and titania nanoparticles for the detection of glutamate in hypoxic 
environments. Biosens. Bioelectron. 2014, 52, 397–402. 
66. Biji, P.; Patnaik, A. Interfacial Janus gold nanoclusters as excellent phase- and orientation-specific 
dopamine sensors. Analyst 2012, 137, 4795–4801. 
67. Herr, N.R.; Park, J.; McElligott, Z.A.; Belle, A.M.; Carelli, R.M.; Wightman, R.M. In vivo 
voltammetry monitoring of electrically evoked extracellular norepinephrine in subregions of the 
bed nucleus of the stria terminalis. J. Neurophysiol. 2012, 107, 1731–1737. 
68. Azzopardi, C.; Azzopardi, M.; Muscat, R.; Camilleri, K.P. Investigating linear superposition of 
multi-species neurotransmitter voltammetric measurements in-vitro. In Proceedings of 
Engineering in Medicine and Biology Society (EMBC), 2012 Annual International Conference 
of the IEEE, San Diego, CA, USA, 28 August–1 September 2012; pp. 3527–3530. 
69. Liu, L.; Du, J.M.; Li, S.J.; Yuan, B.Q.; Han, H.X.; Jing, M.; Xia, N. Amplified voltammetric 
detection of dopamine using ferrocene-capped gold nanoparticle/streptavidin conjugates.  
Biosens. Bioelectron. 2013, 41, 730–735. 
70. Iijima, S. Helical microtubules of graphitic carbon. Nature 1991, 354, 56–58. 
71. Wang, X.; Liu, Z. Carbon nanotubes in biology and medicine: An overview. Chin. Sci. Bull. 
2012, 57, 167–180. 
72. Lee, G.J.; Lim, J.E.; Park, J.H.; Choi, S.K.; Hong, S.; Park, H.K. Neurotransmitter detection by 
enzyme-immobilized CNT-FET. Curr. Appl. Phys. 2009, 9, S25–S28. 
73. Xiao, N.; Venton, B.J. Rapid, sensitive detection of neurotransmitters at microelectrodes 
modified with self-assembled SWCNT forests. Anal. Chem. 2012, 84, 7816–7822. 
74. Gholizadeh, A.; Shahrokhian, S.; Zad, A.I.; Mohajerzadeh, S.; Vosoughi, M.; Darbari, S.;  
Sanaee, Z. Mediator-Less highly sensitive voltammetric detection of glutamate using glutamate 
dehydrogenase/vertically aligned CNTs grown on silicon substrate. Biosens. Bioelectron. 2012, 
31, 110–115. 
75. Jacobs, C.B.; Vickrey, T.L.; Venton, B.J. Functional groups modulate the sensitivity and electron 
transfer kinetics of neurochemicals at carbon nanotube modified microelectrodes. Analyst 2011, 
136, 3557–3565. 
Sensors 2014, 14 18006 
 
 
76. Njagi, J.; Ball, M.; Best, M.; Wallace, K.N.; Andreescu, S. Electrochemical quantification of 
serotonin in the live embryonic zebrafish intestine. Anal. Chem. 2010, 82, 1822–1830. 
77. Goyal, R.N.; Bishnoi, S. A novel multi-walled carbon nanotube modified sensor for the selective 
determination of epinephrine in smokers. Electrochim. Acta 2011, 56, 2717–2724. 
78. Goyal, R.N.; Bishnoi, S. Simultaneous determination of epinephrine and norepinephrine in 
human blood plasma and urine samples using nanotubes modified edge plane pyrolytic graphite 
electrode. Talanta 2011, 84, 78–83. 
79. Kamyabi, M.A.; Narimani, O.; Monfared, H.H. Electroless deposition of bis(4'-(4-Pyridyl)-2,2':6',  
2''-terpyridine)iron(II) thiocyanate complex onto carbon nanotubes modified glassy carbon 
electrode: Application to simultaneous determination of ascorbic acid, dopamine and uric acid.  
J Brazil Chem. Soc. 2011, 22, 468–477. 
80. Babaei, A.; Babazadeh, M.; Afrasiabi, M. A sensitive simultaneous determination of adrenalin 
and paracetamol on a glassy carbon electrode coated with a film of chitosan/room temperature 
ionic liquid/single-walled carbon nanotubes nanocomposite. Chin. J. Chem. 2011, 29, 2157–2164. 
81. Koehne, J.E.; Marsh, M.; Boakye, A.; Douglas, B.; Kim, I.Y.; Chang, S.Y.; Jang, D.P.; Bennet, K.E.; 
Kimble, C.; Andrews, R.; et al. Carbon nanofiber electrode array for electrochemical detection of 
dopamine using fast scan cyclic voltammetry. Analyst 2011, 136, 1802–1805. 
82. Bledsoe, J.M.; Kimble, C.J.; Covey, D.P.; Blaha, C.D.; Agnesi, F.; Mohseni, P.; Whitlock, S.; 
Johnson, D.M.; Horne, A.; Bennet, K.E.; et al. Development of the Wireless Instantaneous 
Neurotransmitter Concentration System for intraoperative neurochemical monitoring using  
fast-scan cyclic voltammetry. Technical note. J. Neurosurg. 2009, 111, 712–723. 
83. Heister, E.; Brunner, E.W.; Dieckmann, G.R.; Jurewicz, I.; Dalton, A.B. Are carbon nanotubes  
a natural solution? Applications in biology and medicine. ACS Appl. Mater. Interfaces 2013, 5, 
1870–1891. 
84. Ali-Boucetta, H.; Kostarelos, K. Carbon nanotubes in medicine & biology—Therapy and 
diagnostics. Adv. Drug Deliv. Rev. 2013, 65, 1897–1898. 
85. Liu, Z.; Tabakman, S.; Welsher, K.; Dai, H. Carbon nanotubes in biology and medicine: In vitro 
and in vivo detection, imaging and drug delivery. Nano Res. 2009, 2, 85–120. 
86. Abbaspour, A.; Noori, A. A cyclodextrin host-guest recognition approach to an electrochemical 
sensor for simultaneous quantification of serotonin and dopamine. Biosens. Bioelectron. 2011, 
26, 4674–4680. 
87. Ly, S.Y. Determination of epinephrine in carp brain cells by square-wave anodic stripping 
voltammetry with carbon nanotubes. Anal. Lett. 2012, 45, 1197–1203. 
88. Ross, A.E.; Venton, B.J. Nafion-CNT coated carbon-fiber microelectrodes for enhanced detection of 
adenosine. Analyst 2012, 137, 3045–3051. 
89. Lin, L.; Cai, Y.P.; Lin, R.P.; Yu, L.; Song, C.Y.; Gao, H.C.; Li, X.K. New integrated in vivo 
microdialysis-electrochemical device for determination of the neurotransmitter dopamine in rat 
striatum of freely moving rats. Microchim. Acta 2011, 172, 217–223. 
90. Li, B.R.; Hsieh, Y.J.; Chen, Y.X.; Chung, Y.T.; Pan, C.Y.; Chen, Y.T. An ultrasensitive  
nanowire-transistor biosensor for detecting dopamine release from living PC12 cells under 
hypoxic stimulation. J. Am. Chem. Soc. 2013, 135, 16034–16037. 
Sensors 2014, 14 18007 
 
 
91. De la Rosa, J.M.; Castro-Lopez, R.; Morgado, A.; Becerra-Alvarez, E.C.; del Rio, R.;  
Fernandez, F.V.; Perez-Verdu, B. Adaptive CMOS analog circuits for 4G mobile terminals-review 
and state-of-the-art survey. Microelectron. J. 2009, 40, 156–176. 
92. Adiguzel, Y.; Kulah, H. CMOS cell sensors for point-of-care diagnostics. Sensors 2012, 12,  
10042–10066. 
93. Ohta, J.; Tokuda, T.; Sasagawa, K.; Noda, T. Implantable CMOS biomedical devices. Sensors 
2009, 9, 9073–9093. 
94. Graham, A.H.D.; Robbins, J.; Bowen, C.R.; Taylor, J. Commercialisation of CMOS integrated 
circuit technology in multi-electrode arrays for neuroscience and cell-based biosensors. Sensors 
2011, 11, 4943–4971. 
95. Joo, S.; Brown, R.B. Chemical sensors with integrated electronics. Chem. Rev. 2008, 108,  
638–651. 
96. Thewes, R. CMOS chips for bio molecule sensing purposes. In Proceedings of 2007 2nd 
International Workshop on Advances in Sensors and Interface (IWASI 2007), Bari, Italy, 26–27 
June 2007; pp. 1–6. 
97. Franks, W.; Schenker, I.; Schmutz, P.; Hierlemann, A. Impedance characterization and modeling 
of electrodes for biomedical applications. IEEE Trans. Biomed. Eng. 2005, 52, 1295–1302. 
98. Lu, M.S.C.; Chen, Y.C.; Huang, P.C. 5 × 5 CMOS capacitive sensor array for detection of the 
neurotransmitter dopamine. Biosens. Bioelectron. 2010, 26, 1093–1097. 
99. Ayers, S.; Berberian, K.; Gillis, K.D.; Lindau, M.; Minch, B.a. Post-CMOS fabrication of 
working electrodes for on-chip recordings of transmitter release. IEEE Trans. Biomed. Circuits 
Syst. 2010, 4, 86–92. 
100. Wang, S.W.; Lu, M.S.C. CMOS capacitive sensors with sub-mu m microelectrodes for 
biosensing applications. IEEE Sens. J. 2010, 10, 991–996. 
101. Kim, B.N.; Herbst, A.D.; Kim, S.J.; Minch, B.A.; Lindau, M. Parallel recording of 
neurotransmitters release from chromaffin cells using a 10 × 10 CMOS IC potentiostat array with 
on-chip working electrodes. Biosens. Bioelectron. 2013, 41, 736–744. 
102. Nazari, M.H.; Mazhab-Jafari, H.; Guenther, A.; Genov, R. 192-Channel CMOS neurochemical 
microarray. In Proceedings of the 2010 IEEE Custom Integrated Circuits Conference (CICC),  
San Jose, CA, USA, 19–22 September 2010; pp. 1–4. 
103. Poustinchi, M.; Musallam, S. Low power noise immune circuit for implantable CMOS 
neurochemical sensor applied in neural prosthetics. In Proceedings of the 2011 5th International 
IEEE/EMBS Conference on Neural Engineering, Cancun, Mexico, 27 April–1 May 2011;  
pp. 695–699. 
104. Graham, A.H.D.; Surguy, S.M.; Langlois, P.; Bowen, C.R.; Taylor, J.; Robbins, J. Modification 
of standard CMOS technology for cell-based biosensors. Biosens. Bioelectron. 2012, 31, 458–462. 
105. Jang, B.; Hassibi, A. Biosensor systems in standard CMOS processes: Fact or fiction?  
IEEE Trans. Ind. Electron. 2009, 56, 979–985. 
106. Huang, C.W.; Lu, M.S.C. Electrochemical detection of the neurotransmitter dopamine by 
nanoimprinted interdigitated electrodes and a CMOS circuit with enhanced collection efficiency. 
IEEE Sens. J. 2011, 11, 1826–1831. 
Sensors 2014, 14 18008 
 
 
107. Lee, B.Y.; Seo, S.M.; Lee, D.J.; Lee, M.; Lee, J.; Cheon, J.H.; Cho, E.; Lee, H.; Chung, I.Y.;  
Park, Y.J.; et al. Biosensor system-on-a-chip including CMOS-based signal processing circuits 
and 64 carbon nanotube-based sensors for the detection of a neurotransmitter. Lab Chip 2010, 10,  
894–898. 
108. Miled, M.A.; Sawan, M. Electrode robustness in artificial cerebrospinal fluid for dielectrophoresis-
based LoC. In Proceedings of Engineering in Medicine and Biology Society (EMBC), 2012 
Annual International Conference of the IEEE, San Diego, CA, USA, 28 August–1 September 
2012; pp. 1390–1393. 
109. Miled, M.; Sawan, M. Dielectrophoresis-based integrated lab-on-chip for nano and micro-particles 
manipulation and capacitive detection. IEEE Trans. Biomed. Circuits Syst. 2012, 6, 120–132. 
110. Nabovati, G.; Ghafar-Zadeh, E.; Mirzaei, M.; Ayala-Charca, G.; Awwad, F.; Sawan, M. A New 
Fully Differential Capacitance to Digital Converter for Lab-on-Chip Based Sensing Applications. 
IEEE Trans. Biomed. Circuits Syst. 2014, 99, 1. 
111. Massicotte, G.; Sawan, M. An Efficient Time-Based CMOS Potentiostat for Neurotransmitters 
Sensing. In Proceedings of the 2013 IEEE International Symposium on Medical Measurements 
and Applications Proceedings (MeMeA), Gatineau, QC, Canada, 4–5 May 2013; pp. 274–277. 
112. Rosen, S.G.; Linares, O.A.; Sanfield, J.A.; Zech, L.A.; Lizzio, V.P.; Halter, J.B. Epinephrine 
kinetics in humans: Radiotracer methodology. J. Clin. Endocrinol. Metab. 1989, 69, 753–761. 
113. Goldstein, D.S.; Eisenhofer, G.; Kopin, I.J. Sources and significance of plasma levels of 
catechols and their metabolites in humans. J. Pharmacol. Exp. Ther. 2003, 305, 800–811. 
114. Rouzaud Laborde, C.; Delmas, C.; Mialet-Perez, J.; Pizzinat, N.; Biendel-Picquet, C.; Boudou, N.; 
Dumonteil, N.; Spreux-Varoquaux, O.; Carrie, D.; Galinier, M.; et al. First evidence of increased 
plasma serotonin levels in Tako-Tsubo cardiomyopathy. BioMed. Res. Int. 2013, 2013, 847069. 
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
